This provocative meeting is intended to bring together all those concerned about drug discovery (academia, industry, biotech, funders, charities and patient groups) to openly debate the bottlenecks that are hindering innovation and generation of tangible results. Our vision is to establish practical opportunities to map and create better, more efficient approaches for this quickly-evolving ecosystem.
The conference will consist of six panels discussing different scientific and strategic challenges, each composed by three panellists and two chairs. Individual talks by the panellists will be followed by critical and direct questioning by the chairs, who will encourage audience participation.
Opening
Plenary talk I
Session 1: "The new era of genomics and big data: will it deliver this time?"
Session 2: "Phenotypic screening and human tissue platforms: a new fad or a transformational tool for reliable target validation?"
Session 3: "The impact of chemical biology in drug discovery: how far can we push it?"
Day 2 , 3rd June 2016 :
Plenary talk II
Session 4: "Antibiotics and neglected diseases: ripe opportunities to create open source medicines/ pharma?"
Session 5: "The birth of a new ecosystem: who are the new actors and are the traditional ones obsolete?"
Session 6: "New therapeutic strategies: beyond conventional biologics and medicinal chemistry"
Closing session
The conference will consist of six panels discussing different scientific and strategic challenges, each composed by three panellists and two chairs. Individual talks by the panellists will be followed by critical and direct questioning by the chairs, who will encourage audience participation.
Drug discovery: creating a new ecosystem: Programme
Day 1 , 2nd June 2016 :Opening
Plenary talk I
Session 1: "The new era of genomics and big data: will it deliver this time?"
Session 2: "Phenotypic screening and human tissue platforms: a new fad or a transformational tool for reliable target validation?"
Session 3: "The impact of chemical biology in drug discovery: how far can we push it?"
Day 2 , 3rd June 2016 :
Plenary talk II
Session 4: "Antibiotics and neglected diseases: ripe opportunities to create open source medicines/ pharma?"
Session 5: "The birth of a new ecosystem: who are the new actors and are the traditional ones obsolete?"
Session 6: "New therapeutic strategies: beyond conventional biologics and medicinal chemistry"
Closing session
